Skip to main content
CELL BIOTECH CO ., LTD logo

CELL BIOTECH CO ., LTD — Investor Relations & Filings

Ticker · 049960 ISIN · KR7049960008 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2021-02-25 AGM Information
Country KR South Korea
Listing KO 049960

About CELL BIOTECH CO ., LTD

https://www.cellbiotech.com/

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Cell Biotech. It outlines the date, location, and agenda items (such as financial statement approval, director compensation, and articles of incorporation changes). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-02-25 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from Cell Biotech regarding a 'Cash/In-kind Dividend Decision' (현금ㆍ현물배당 결정). It details the dividend amount per share, the total dividend amount, the dividend record date, and the scheduled date for the general meeting of shareholders. This falls under the category of dividend announcements.
2021-02-25 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a preliminary earnings release (잠정실적) for Cell Biotech, detailing quarterly and cumulative financial performance (revenue, operating profit, net income) for the 4th quarter of 2020. It explicitly states that these are preliminary figures subject to change upon audit. This fits the definition of an Earnings Release (ER), which provides initial highlights of financial results. Q4 2020
2021-02-19 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a regulatory filing from a Korean company (Cell Biotech) regarding the extension of a trust agreement for the acquisition of its own shares (treasury stock). It follows the standard format for a 'Major Matter Report' (주요사항보고서) as required by the Korea Exchange. Since the document details the company's decision to buy back or manage its own shares through a trust, it falls under the category of 'Transaction in Own Shares'.
2021-01-29 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given the nature of the filing as a standard regulatory notification, it fits best under the RNS category.
2020-12-16 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting (Non-Deal Roadshow). It provides details such as the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Investor Presentation', it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure.
2020-11-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.